Licita Farmacos de Seccion 262 Refrigerados Anual 2012
Necesidad de abstecer de farmacos de la seccion 262 refrigerados, en base a prog anual 2012
16 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 4309-935-SE13 | 11-02-2013 | Corporacion Nacional del Cancer | $782.333 |
| 4309-933-SE13 | 11-02-2013 | Allergan Laboratorios Limitada | $11.430.414 |
| 4309-934-SE13 | 11-02-2013 | Alpes Selection Productos Farmaceuticos Ltda. | $12.737.998 |
| 4309-938-SE13 | 11-02-2013 | Inversiones Pmg S.A. | $1.035.300 |
| 4309-936-SE13 | 11-02-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $956.743 |
| 4309-937-SE13 | 11-02-2013 | Pfizer Chile S.A. | $1.633.763 |
| 4309-5616-SE12 | 07-02-2013 | Alpes Selection Productos Farmaceuticos Ltda. | $2.420.460 |
| 4309-829-SE13 | 29-01-2013 | Farmaceutica Insuval S.A. | $5.260.990 |
| 4309-20-SE13 | 08-01-2013 | Alpes Selection Productos Farmaceuticos Ltda. | $177.905 |
| 4309-21-SE13 | 08-01-2013 | Corporacion Nacional del Cancer | $289.753 |
| 4309-24-SE13 | 08-01-2013 | Pfizer Chile S.A. | $466.789 |
| 4309-23-SE13 | 08-01-2013 | Farmaceutica Insuval S.A. | $8.044.400 |
| 4309-22-SE13 | 08-01-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $72.968 |
| 4309-5885-SE12 | 28-12-2012 | Fresenius Kabi Chile Limitada | $1.450.610 |
| 4309-5555-SE12 | 14-12-2012 | Fresenius Kabi Chile Limitada | $1.419.075 |
| 4309-5660-SE12 | 11-12-2012 | Glaxosmithkline Chile Farmaceutica Limitada | $72.968 |
| 4309-5658-SE12 | 11-12-2012 | Alpes Selection Productos Farmaceuticos Ltda. | $177.905 |
| 4309-5659-SE12 | 11-12-2012 | Corporacion Nacional del Cancer | $173.852 |
| 4309-5661-SE12 | 11-12-2012 | Farmaceutica Insuval S.A. | $4.392.290 |
| 4309-5662-SE12 | 11-12-2012 | Inversiones Pmg S.A. | $59.500 |
| 4309-4708-SE12 | 15-11-2012 | Inversiones Pmg S.A. | $71.400 |
| 4309-5073-SE12 | 15-11-2012 | Alpes Selection Productos Farmaceuticos Ltda. | $498.134 |
| 4309-5081-SE12 | 15-11-2012 | Farmaceutica Insuval S.A. | $987.700 |
| 4309-5090-SE12 | 31-10-2012 | Fresenius Kabi Chile Limitada | $3.468.850 |
| 4309-4633-SE12 | 30-10-2012 | Glaxosmithkline Chile Farmaceutica Limitada | $51.634 |
| 4309-4631-SE12 | 18-10-2012 | Alpes Selection Productos Farmaceuticos Ltda. | $711.620 |
| 4309-4632-SE12 | 18-10-2012 | Corporacion Nacional del Cancer | $115.901 |
| 4309-4704-SE12 | 12-10-2012 | Fresenius Kabi Chile Limitada | $3.468.850 |
| 4309-2349-SE12 | 11-09-2012 | Allergan Laboratorios Limitada | $243.200 |
| 4309-4186-SE12 | 11-09-2012 | Inversiones Pmg S.A. | $119.000 |
| 4309-4187-SE12 | 11-09-2012 | Pfizer Chile S.A. | $466.789 |
| 4309-4188-SE12 | 11-09-2012 | Alpes Selection Productos Farmaceuticos Ltda. | $569.296 |
| 4309-4102-SE12 | 10-09-2012 | Fresenius Kabi Chile Limitada | $2.522.800 |
| 4309-3846-SE12 | 21-08-2012 | Inversiones Pmg S.A. | $71.400 |
| 4309-3673-SE12 | 13-08-2012 | Fresenius Kabi Chile Limitada | $3.468.850 |
| 4309-3122-SE12 | 11-07-2012 | Glaxosmithkline Chile Farmaceutica Limitada | $15.150 |
| 4309-3120-SE12 | 11-07-2012 | Corporacion Nacional del Cancer | $231.802 |
| 4309-3121-SE12 | 11-07-2012 | Fresenius Kabi Chile Limitada | $3.784.200 |
| 4309-3123-SE12 | 11-07-2012 | Farmaceutica Insuval S.A. | $773.500 |
| 4309-3124-SE12 | 11-07-2012 | Pfizer Chile S.A. | $466.789 |
| 4309-2347-SE12 | 11-06-2012 | Glaxosmithkline Chile Farmaceutica Limitada | $109.453 |
| 4309-2352-SE12 | 11-06-2012 | Inversiones Pmg S.A. | $71.400 |
| 4309-2346-SE12 | 24-05-2012 | Corporacion Nacional del Cancer | $144.877 |
| 4309-2348-SE12 | 24-05-2012 | Pfizer Chile S.A. | $233.395 |
| 4309-2350-SE12 | 24-05-2012 | Fresenius Kabi Chile Limitada | $2.901.220 |
| 4309-2351-SE12 | 24-05-2012 | Farmaceutica Insuval S.A. | $11.775.050 |
| 4309-2353-SE12 | 24-05-2012 | Alpes Selection Productos Farmaceuticos Ltda. | $498.134 |
Fuente original:ficha mercadopublico.cl
